April 10, 2024
Medical Microinstruments (MMI) said it has been granted De Novo Classification for a robotic system that enables soft tissue manipulation to perform microsurgery.
The Jacksonville, FL-based company said the Symani Surgical System performs a highly specialized technique that involves reconnecting tiny vessels to restore blood flow or redirect fluid during reconstruction or repair.
The company said the Symani Surgical System offers surgeons entirely new capabilities because it features a small surgical robotic wrist, called NanoWrist.
The company said the design enables surgeons to replicate the natural movements of the human hand at the micro-scale, which encourages a flatter learning curve in the training process. The articulated wrist features seven degrees of freedom that match the human wrist, tremor filtration, and motion scaling, ultimately increasing precision and control.
Mark Toland, MMI’s CEO said the device fills an important need in the realm of microsurgery.
The U.S. is facing a potentially dire shortage of physicians, and that shortage acutely impacts specialized fields of medicine, such as microsurgery,” said Mark Toland, CEO of MMI. “With the authorization from FDA, our technology will expand its reach to pioneering hospitals in the U.S. It will help those hospitals grow their open surgical programs, expand the number of physicians who can perform these highly complicated procedures, and increase patient access to the most advanced techniques for surgeries in complex disease states, such as lymphedema. Our system will continue to provoke surgeons to challenge their definitions of ‘treatable’ and ‘untreatable’ and empower them to solve cases that have historically been too difficult to treat.”
About the Author
You May Also Like